The purpose of this study is to investigate the efficacy and effectiveness of peginterferon
alfa-2a and ribavirin therapy in Korean chronic hepatitis C patients.
Drug: Peginterferon alfa-2a plus ribavirin for HCV genotype 1
Drug: Peginterferon alfa-2a plus ribavirin for HCV genotype 2/3
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01596517
Ages eligible for Study
18 Years to 70 Years
Genders eligible for Study
Accepts Healthy Volunteers
all of below
adults aged 18-70 years
serum anti-HCV antibody (+)
HCV RNA detectable by PCR
compensated liver disease (Child-Pugh class A)
any of below
HCV genotype other than 1, 2, or 3
acute hepatitis C
decompensated cirrhosis or hepatocellular carcinoma
other liver disease such as hepatitis A or B, or autoimmune hepatitis
severe depression or other psychiatric disease
previous organ transplantation
absolute neutrophil count (ANC) < 1,000 cells/mm3 or platelet count < 75,000 cells/mm3, or hemoglobin (Hb) < 13 g/dL for men, <12 g/dL for women
All locations for NCT01596517
Korea, Republic of (1)
Asan Medical Center
Seoul, Korea, Republic of, 138-736
View full eligibility
Tris trial is registered with FDA with number: NCT01596517. The sponsor of the trial is Asan Medical Center and it is looking for 272 volunteers for the current phase.
Official trial title: Efficacy and Effectiveness of Combination Therapy With Pegylated Interferon Alfa-2a and Ribavirin in Korean Patients With Chronic Hepatitis C
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.